•
Dec 31, 2022

Bausch + Lomb Q4 2022 Earnings Report

Bausch + Lomb reported mixed results for Q4 2022, with revenues in line with the previous year but a net loss reported. The company highlighted organic revenue growth across all segments and progress in its separation from Bausch Health.

Key Takeaways

Bausch + Lomb's Q4 2022 revenues were $996 million, in line with Q4 2021. The company reported a GAAP net loss of $1 million, and adjusted EBITDA was $181 million. Organic revenue grew by 5%, driven by growth across all segments. The company is undergoing a CEO transition, with Brent Saunders set to take over in March 2023.

Revenues of $996 million were in line with the fourth quarter of 2021.

GAAP net loss attributable to Bausch + Lomb Corporation was $1 million.

Adjusted EBITDA (non-GAAP) was $181 million.

Organic revenues grew 5%, driven by organic growth across all segments.

Total Revenue
$996M
Previous year: $1B
-0.5%
EPS
$0.23
Previous year: $0.15
+53.3%
Cash and Equivalents
$380M
Previous year: $174M
+118.4%

Bausch + Lomb

Bausch + Lomb

Bausch + Lomb Revenue by Segment

Forward Guidance

Bausch + Lomb will provide expectations on its first-quarter 2023 outlook during the call today at 8 a.m. ET; however, given the appointment of Mr. Saunders as CEO and chair of the Board, effective March 6, 2023, the Company will provide full guidance for 2023 when it provides first-quarter 2023 results.